GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reflect Scientific Inc (OTCPK:RSCF) » Definitions » Return-on-Tangible-Equity

Reflect Scientific (Reflect Scientific) Return-on-Tangible-Equity : -7.04% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Reflect Scientific Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Reflect Scientific's annualized net income for the quarter that ended in Mar. 2024 was $-0.13 Mil. Reflect Scientific's average shareholder tangible equity for the quarter that ended in Mar. 2024 was $1.82 Mil. Therefore, Reflect Scientific's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was -7.04%.

The historical rank and industry rank for Reflect Scientific's Return-on-Tangible-Equity or its related term are showing as below:

RSCF' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -88.74   Med: -31.89   Max: 80.19
Current: -17.74

During the past 13 years, Reflect Scientific's highest Return-on-Tangible-Equity was 80.19%. The lowest was -88.74%. And the median was -31.89%.

RSCF's Return-on-Tangible-Equity is ranked worse than
64.12% of 758 companies
in the Medical Devices & Instruments industry
Industry Median: 1.24 vs RSCF: -17.74

Reflect Scientific Return-on-Tangible-Equity Historical Data

The historical data trend for Reflect Scientific's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reflect Scientific Return-on-Tangible-Equity Chart

Reflect Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.22 80.19 57.38 4.09 -22.56

Reflect Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.33 -36.05 17.48 -44.91 -7.04

Competitive Comparison of Reflect Scientific's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Reflect Scientific's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reflect Scientific's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Reflect Scientific's Return-on-Tangible-Equity falls into.



Reflect Scientific Return-on-Tangible-Equity Calculation

Reflect Scientific's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-0.459/( (2.237+1.833 )/ 2 )
=-0.459/2.035
=-22.56 %

Reflect Scientific's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-0.128/( (1.833+1.801)/ 2 )
=-0.128/1.817
=-7.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Reflect Scientific  (OTCPK:RSCF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Reflect Scientific Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Reflect Scientific's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Reflect Scientific (Reflect Scientific) Business Description

Traded in Other Exchanges
N/A
Address
1266 South 1380 West, Orem, UT, USA, 84058
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The company serves a varies array of customers including hospitals and diagnostic laboratories, pharmaceutical and biotech companies, universities, government and private sector research facilities, and chemical and industrial companies. The products of the company are Cryometrix Freezers which provides energy savings and other critically important benefits to cryo-storage customers in the Life Science related industries, and detectors that serve the analytical instrumentation sector of the Life Sciences market. The company sells its products in the biotechnology, pharmaceutical, and medical industries.
Executives
Kim Boyce director, 10 percent owner, officer: President 1266 SOUTH 1380 WEST, OREM UT 84058
Keith L Merrell officer: CFO 1240 MUELLER PARK ROAD, BOUNTIFUL UT 84010
William G Moon director 1266 SOUTH 1380 WEST, OREM UT 84058
David Scott Strate officer: CFO 1270 S 1380 W, OREM UT 84058
Kevin Cooksy officer: Secretary Treasurer 3161 GRANADA DRIVE, CAMERON PARK CA 95682
Craig Morrison director 975 NORTH TERRACE DRIVE, PROVO UT 84604
Thomas A Tait director, officer: Vice President 514 AMERICAS WAY #5556, BOX ELDER SD 57719